The table below shows BIOCRYST PHARMACEUTICALS INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$874.84M
$450.71M
$331.41M
$270.83M
$157.17M
$17.81M
Cost of revenue
$19.07M
$12.27M
$4.48M
$6.41M
$7.23M
$1.55M
Gross profit
-
-
-
-
-
-
R&D
$166.13M
$174.64M
$216.57M
$253.30M
$208.81M
$122.96M
SG&A
BCRX annual revenue (10-K history)
BIOCRYST PHARMACEUTICALS INC reported annual revenue of $874.84M for fiscal year 2025. That is up 94.1% from $450.71M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $26.35M (FY 2016) to $874.84M. Figures come from the company's audited annual reports as filed with the SEC.
